Immix Biopharma Inc
Ownership
Ownership Structure
Who owns Immix Biopharma Inc (IMMX)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 70.3% of the shares are freely tradable; institutional investors hold 45.1%.
Largest Shareholders
Funds
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| Eventide Healthcare & Life Sciences I | 4.69 | 3,891,019 | +52.6 | 06/30/2026 |
| Vanguard MStar Total Stk Mkt Idx Invest | 2.70 | 2,236,995 | +25.6 | 09/30/2026 |
| State Street® SPDR® S&P® Biotech ETF | 2.59 | 2,150,073 | -0.8 | 10/29/2026 |
| Janus Henderson Hrzn Biotec E2 USD | 2.35 | 1,948,280 | +34.1 | 06/30/2026 |
| iShares Russell 2000 ETF | 1.81 | 1,501,885 | -0.4 | 10/29/2026 |
| Franklin Biotechnology Discv A(acc)USD | 1.38 | 1,142,148 | +86.6 | 09/30/2026 |
| Columbia Small Cap Growth Inst | 1.19 | 986,315 | +31.6 | 09/30/2026 |
| Franklin Biotechnology Discovery A | 0.78 | 645,099 | +80.7 | 09/30/2026 |
| iShares Russell 2000 Growth ETF | 0.68 | 560,052 | +0.3 | 10/29/2026 |
| Columbia Small Cap Value Discv A | 0.59 | 490,230 | +0.7 | 09/30/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Data as of: November 3, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.